Table 1 Clinical characteristics in the control group and the LIPUS group.
Variables | Control group (n = 12) | LIPUS group (n = 12) |
|---|---|---|
Age, year | 45.9 ± 8.7 | 46.7 ± 8.9 |
Gender, men/women | 11/1 | 10/2 |
Body mass index, kg/m2 | 22.5 ± 3.1 | 22.7 ± 2.9 |
Rutherford category, n (%) | Â | Â |
3 | 2 (17) | 2 (17) |
4 | 4 (33) | 3 (25) |
5 | 5 (42) | 6 (50) |
6 | 1 (8) | 1 (8) |
Complications, n (%) | Â | Â |
Hypertension | 2 (17) | 3 (25) |
Diabetes mellitus | 3 (25) | 3 (25) |
Dyslipidemia | 3 (25) | 3 (25) |
Pervious myocardial infarction | 0 (0) | 0 (0) |
Pervious stroke | 0 (0) | 0 (0) |
Medication, n (%) | Â | Â |
Anti-platelets | 9 (75) | 8 (67) |
ARBs | 2 (17) | 1 (8) |
Calcium channel blockers | 1 (8) | 1 (8) |
Statins | 3 (25) | 2 (17) |
Sulfonylurea and/or metformin | 1 (8) | 1 (8) |
Smoker, n (%) | 3 (25) | 3 (25) |
